Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

被引：0
|
作者：
Fumitaka Suzuki
Tetsuya Hosaka
Yoshiyuki Suzuki
Hitomi Sezaki
Norio Akuta
Shunichiro Fujiyama
Yusuke Kawamura
Masahiro Kobayashi
Satoshi Saitoh
Yasuji Arase
Kenji Ikeda
Mariko Kobayashi
Rie Mineta
Yukiko Suzuki
Hiromitsu Kumada
机构：
[1] Toranomon Hospital,Department of Hepatology
[2] Okinaka Memorial Institute for Medical Research,Research Institute for Hepatology
[3] Toranomon Branch Hospital,undefined
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Hepatitis B virus; Entecavir; HBsAg seroclearance; Resistance; Viral breakthrough;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：182 / 193
页数：11
相关论文
共 50 条
  • [1] Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients in Japan
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Suzuki, Yoshiyuki
    Sezaki, Hitomi
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (02) : 182 - 193
  • [2] A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
    Kayaaslan, Bircan
    Akinci, Esragul
    Ari, Alpay
    Tufan, Zeliha Kocak
    Alpat, Saygin Nayman
    Gunal, Ozgur
    Tosun, Selma
    Guner, Rahmet
    Tabak, Fehmi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (01) : 40 - 47
  • [3] Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients
    Ono, Atsushi
    Suzuki, Fumitaka
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitou, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Watahiki, Sachiyo
    Mineta, Rie
    Kumada, Hiromitsu
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 508 - 514
  • [4] Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ridruejo, Ezequiel
    Silva, Marcelo O.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 357 - 360
  • [5] LONG-TERM ANTIVIRAL EFFECT OF ENTECAVIR IN CHRONIC HEPATITIS B PATIENTS WITH PRIOR EXPOSURE TO NUCLEOS(T)IDE ANALOGUES
    Chen, Chien-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Lee, Chuan-Mo
    HEPATOLOGY, 2011, 54 : 1035A - 1035A
  • [6] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [7] Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
    Lai, Ching-Lung
    Wong, Danny
    Ip, Philip
    Kopaniszen, Malgorzata
    Seto, Wai-Kay
    Fung, James
    Huang, Fung-Yu
    Lee, Brian
    Cullaro, Giuseppe
    Chong, Chun Kong
    Wu, Ringo
    Cheng, Charles
    Yuen, John
    Ngai, Vincent
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 275 - 281
  • [8] The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
    Coffin, C. S.
    Rezaeeaval, M.
    Pang, J. X.
    Alcantara, L.
    Klein, P.
    Burak, K. W.
    Myers, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1262 - 1269
  • [9] Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
    Broquetas, Teresa
    Carrion, Jose A.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2022, 14 : 87 - 100
  • [10] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Moreno-Cubero, Elia
    Sanchez del Arco, Robert T.
    Pena-Asensio, Julia
    Sanz de Villalobos, Eduardo
    Miquel, Joaquin
    Ramon Larrubia, Juan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (17) : 1825 - 1838
12345